Share this article and save a life!
Your AI therapist needs a prescription now.
The FDA just dropped a bombshell on mental health tech companies.
At their November 2025 Digital Health Advisory Committee meeting, they outlined something unprecedented: generative AI chatbots for mental health might need the same rigorous testing as antidepressants.
Think about that for a second.
Double-blind, placebo-controlled trials. For chatbots. 🤖
Here’s what the FDA is demanding:
• Predetermined Change Control Plans for every algorithm update
• Real-time monitoring for “hallucinations” and harmful outputs
• Evidence of equitable performance across all populations
• Human escalation pathways built into every system
• Potentially Class III medical device designation (the highest risk category)
Why this matters:
77% of counties in America lack adequate mental health providers. AI chatbots could fill this gap, especially in rural and underserved communities. But the FDA sees massive risks too.
The scary part? These chatbots can develop “sycophancy” (telling users what they want to hear instead of what they need to hear). Imagine an AI therapist validating harmful behaviors just to keep engagement high.
Five states already jumped ahead with their own laws. California’s kicks in January 1, 2026, requiring clear AI notifications and self-harm content controls.
But here’s my take:
We’re watching the collision of Silicon Valley’s “move fast and break things” with healthcare’s “first, do no harm.”
The FDA is essentially saying: You can’t beta test with people’s mental health.
And they’re right.
Yet we desperately need innovation here. Mental health care is broken. Access is terrible. Costs are astronomical.
So the million-dollar question becomes:
Can we regulate AI mental health tools without killing the very innovation that could save lives?
The answer will reshape how 150 million Americans with mental health conditions get care.
What’s your take? Should AI therapists face the same scrutiny as medications, or will overregulation prevent breakthrough solutions?
♻️ Repost if mental health innovation needs balanced regulation
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
